Table 1. Cannabinoid Derived Pharmaceutical Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Cannabinoid Derived Pharmaceutical Market Restraints

Table 3. Cannabinoid Derived Pharmaceutical Market Trends

Table 4. Cannabinoid Derived Pharmaceutical Industry Policy

Table 5. Global Cannabinoid Derived Pharmaceutical Revenue by Company, 2019-2024, US$ million

Table 6. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Company, 2019-2024

Table 7. Global Cannabinoid Derived Pharmaceutical Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share by Company, 2019-2024

Table 9. Global Cannabinoid Derived Pharmaceutical Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Cannabinoid Derived Pharmaceutical Mergers & Acquisitions, Expansion Plans

Table 12. Global Cannabinoid Derived Pharmaceutical Manufacturers Product Type

Table 13. China Cannabinoid Derived Pharmaceutical Revenue by Company, 2019-2024, US$ million

Table 14. China Cannabinoid Derived Pharmaceutical Revenue Market Share by Company, 2019-2024

Table 15. China Cannabinoid Derived Pharmaceutical Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Cannabinoid Derived Pharmaceutical Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Cannabinoid Derived Pharmaceutical Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Cannabinoid Derived Pharmaceutical Import & Export Trends

Table 19. Main Sources of China Cannabinoid Derived Pharmaceutical Import

Table 20. Export Destination of China Cannabinoid Derived Pharmaceutical

Table 21. Global Headquarters and Manufacturing Base of Cannabinoid Derived Pharmaceutical Manufacturers

Table 22. Global Major Manufacturers, Cannabinoid Derived Pharmaceutical Capacity Expansion and Future Plans

Table 23. Global Cannabinoid Derived Pharmaceutical Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Cannabinoid Derived Pharmaceutical Production by Region, 2019-2024, (K Units)

Table 25. Global Cannabinoid Derived Pharmaceutical Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Cannabinoid Derived Pharmaceutical Upstream (Raw Materials)

Table 27. Global Cannabinoid Derived Pharmaceutical Typical Customers

Table 28. Cannabinoid Derived Pharmaceutical Typical Distributors

Table 29. By Type, Global Cannabinoid Derived Pharmaceutical Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Cannabinoid Derived Pharmaceutical Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Cannabinoid Derived Pharmaceutical Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Cannabinoid Derived Pharmaceutical Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Cannabinoid Derived Pharmaceutical Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Cannabinoid Derived Pharmaceutical Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Cannabinoid Derived Pharmaceutical Revenue Market Share, 2019-2030

Table 37. By Country, Global Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2019-2030

Table 39. Cara Therapeutics Inc Company Information, Head Office, Market Area and Industry Position

Table 40. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 41. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Cara Therapeutics Inc Company Profile and Main Business

Table 43. Cara Therapeutics Inc Recent Developments

Table 44. Arena Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 45. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 46. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Arena Pharmaceuticals Company Profile and Main Business

Table 48. Arena Pharmaceuticals Recent Developments

Table 49. Cannabics Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position

Table 50. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 51. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Cannabics Pharmaceuticals Inc Company Profile and Main Business

Table 53. Cannabics Pharmaceuticals Inc Recent Developments

Table 54. Echo Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 55. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 56. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Echo Pharmaceuticals Company Profile and Main Business

Table 58. Echo Pharmaceuticals Recent Developments

Table 59. Gw Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 60. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 61. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Gw Pharmaceuticals Company Profile and Main Business

Table 63. Gw Pharmaceuticals Recent Developments

Table 64. Inmed Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 65. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 66. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Inmed Pharmaceuticals Company Profile and Main Business

Table 68. Inmed Pharmaceuticals Recent Developments

Table 69. Insys Therapeutics Inc Company Information, Head Office, Market Area and Industry Position

Table 70. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 71. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Insys Therapeutics Inc Company Profile and Main Business

Table 73. Insys Therapeutics Inc Recent Developments

Table 74. Larapharm Company Information, Head Office, Market Area and Industry Position

Table 75. Larapharm Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 76. Larapharm Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Larapharm Company Profile and Main Business

Table 78. Larapharm Recent Developments

Table 79. Mgc Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position

Table 80. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 81. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Mgc Pharmaceuticals Ltd Company Profile and Main Business

Table 83. Mgc Pharmaceuticals Ltd Recent Developments

Table 84. One World Cannabis Company Information, Head Office, Market Area and Industry Position

Table 85. One World Cannabis Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 86. One World Cannabis Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. One World Cannabis Company Profile and Main Business

Table 88. One World Cannabis Recent Developments

Table 89. Orpheus Medica Company Information, Head Office, Market Area and Industry Position

Table 90. Orpheus Medica Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 91. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Orpheus Medica Company Profile and Main Business

Table 93. Orpheus Medica Recent Developments

Table 94. Receptor Life Sciences Company Information, Head Office, Market Area and Industry Position

Table 95. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 96. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Receptor Life Sciences Company Profile and Main Business

Table 98. Receptor Life Sciences Recent Developments

Table 99. Respirerx Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 100. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 101. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Respirerx Pharmaceuticals Company Profile and Main Business

Table 103. Respirerx Pharmaceuticals Recent Developments

Table 104. Tetra Bio-Pharma Company Information, Head Office, Market Area and Industry Position

Table 105. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 106. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Tetra Bio-Pharma Company Profile and Main Business

Table 108. Tetra Bio-Pharma Recent Developments

Table 109. Cardiol Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 110. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 111. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Cardiol Therapeutics Company Profile and Main Business

Table 113. Cardiol Therapeutics Recent Developments

Table 114. United Cannabis Corporation Company Information, Head Office, Market Area and Industry Position

Table 115. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 116. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. United Cannabis Corporation Company Profile and Main Business

Table 118. United Cannabis Corporation Recent Developments

Table 119. Zynerba Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 120. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications and Application

Table 121. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 122. Zynerba Pharmaceuticals Company Profile and Main Business

Table 123. Zynerba Pharmaceuticals Recent Developments

List of Figure

Figure 1. Cannabinoid Derived Pharmaceutical Picture

Figure 2. By Revenue, Global Cannabinoid Derived Pharmaceutical Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Cannabinoid Derived Pharmaceutical Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Cannabinoid Derived Pharmaceutical Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Cannabinoid Derived Pharmaceutical Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Cannabinoid Derived Pharmaceutical Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Cannabinoid Derived Pharmaceutical Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Cannabinoid Derived Pharmaceutical Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Cannabinoid Derived Pharmaceutical Share of Global Market, 2019-2030

Figure 10. Global Cannabinoid Derived Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Cannabinoid Derived Pharmaceutical Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Cannabinoid Derived Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Cannabinoid Derived Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Cannabinoid Derived Pharmaceutical Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Cannabinoid Derived Pharmaceutical Domestic VS Export, 2022

Figure 16. Global Cannabinoid Derived Pharmaceutical Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Cannabinoid Derived Pharmaceutical Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Cannabinoid Derived Pharmaceutical Production Market Share & Forecast by Region, 2019-2030

Figure 19. Cannabinoid Derived Pharmaceutical Industry Chain

Figure 20. Cannabinoid Derived Pharmaceutical Procurement Model

Figure 21. Cannabinoid Derived Pharmaceutical Sales Model

Figure 22. Cannabinoid Derived Pharmaceutical Sales Channels, Direct Sales and Distribution

Figure 23. Cannabinoid Receptor Type 1 (CB1)

Figure 24. Cannabinoid Receptor Type 2 (CB2)

Figure 25. Others

Figure 26. By Type, Global Cannabinoid Derived Pharmaceutical Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Cannabinoid Derived Pharmaceutical Revenue Market Share, 2019-2030

Figure 28. By Type, Global Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Cannabinoid Derived Pharmaceutical Price, 2019-2030, (US$/Unit)

Figure 31. Epilepsy

Figure 32. Migraine

Figure 33. Multiple Sclerosis

Figure 34. Others

Figure 35. By Application, Global Cannabinoid Derived Pharmaceutical Revenue, 2019-2030, US$ Million

Figure 36. By Application, Global Cannabinoid Derived Pharmaceutical Revenue Market Share, 2019-2030

Figure 37. By Application, Global Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 38. By Application, Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2019-2030

Figure 39. By Application, Global Cannabinoid Derived Pharmaceutical Price, 2019-2030, (US$/Unit)

Figure 40. By Region, Global Cannabinoid Derived Pharmaceutical Revenue Market Share, 2019-2030

Figure 41. By Region, Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2019-2030

Figure 42. North America Cannabinoid Derived Pharmaceutical Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, North America Cannabinoid Derived Pharmaceutical Revenue Market Share, 2022

Figure 44. Europe Cannabinoid Derived Pharmaceutical Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, Europe Cannabinoid Derived Pharmaceutical Revenue Market Share, 2022

Figure 46. Asia Pacific Cannabinoid Derived Pharmaceutical Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country/Region, Asia Pacific Cannabinoid Derived Pharmaceutical Revenue Market Share, 2022

Figure 48. South America Cannabinoid Derived Pharmaceutical Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country, South America Cannabinoid Derived Pharmaceutical Revenue Market Share, 2022

Figure 50. Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. U.S. Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 52. By Company, U.S. Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 53. By Type, U.S. Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 56. By Company, Europe Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 57. By Type, Europe Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 59. China Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 60. By Company, China Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 61. By Type, China Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 64. By Company, Japan Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 65. By Type, Japan Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 68. By Company, South Korea Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 69. By Type, South Korea Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, South Korea Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 71. Southeast Asia Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 72. By Company, Southeast Asia Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 73. By Type, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 75. India Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 76. By Company, India Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 77. By Type, India Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, India Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 79. Middle East & Asia Cannabinoid Derived Pharmaceutical Sales Volume, 2019-2030, (K Units)

Figure 80. By Company, Middle East & Asia Cannabinoid Derived Pharmaceutical Market Share, 2022

Figure 81. By Type, Middle East & Asia Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Middle East & Asia Cannabinoid Derived Pharmaceutical Sales Volume Market Share, 2022 VS 2029

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches